CIK: 0001617201 · Show all filings
Period: Q4 2021 (← Previous) (Next →)
Filing Date: Feb 14, 2022
Total Value ($000): $167,046 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| PRTA | PROTHENA CORP PLC | 441,000 | $21,785 | 13.0% | $23.54 | +135.5% | SHS | G72800108 |
| GLPG | GALAPAGOS NV | 345,900 | $19,069 | 11.4% | $58.27 | — | SPON ADR | 36315X101 |
| — | ALBIREO PHARMA INC | 514,082 | $11,973 | 7.2% | $30.59 | — | COM | 01345P106 |
| — | GALAPAGOS NV | 200,300 | $11,043 | 6.6% | — | — | Call | 36315X901 |
| CUE | CUE BIOPHARMA INC | 829,042 | $9,376 | 5.6% | $15.21 | -15.3% | COM | 22978P106 |
| EHC | ENCOMPASS HEALTH CORP | 122,187 | $7,974 | 4.8% | $49.64 | -0.4% | COM | 29261A100 |
| OSCR | OSCAR HEALTH INC | 925,000 | $7,261 | 4.3% | $14.31 | -12.2% | CL A | 687793109 |
| — | CONVEY HEALTH SOLUTIONS HLDG | 777,000 | $6,496 | 3.9% | $9.97 | — | COM | 21258C108 |
| — | KEZAR LIFE SCIENCES INC | 360,000 | $6,019 | 3.6% | $5.82 | — | COM | 49372L100 |
| — | ZOGENIX INC | 362,909 | $5,897 | 3.5% | $18.57 | — | COM NEW | 98978L204 |
| CRL | CHARLES RIV LABS INTL INC | 15,481 | $5,833 | 3.5% | $388.52 | 0.0% | COM | 159864107 |
| KALV | KALVISTA PHARMACEUTICALS INC | 409,620 | $5,419 | 3.2% | $21.26 | -25.1% | COM | 483497103 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 31,907 | $5,411 | 3.2% | $185.86 | 0.0% | COM | 02043Q107 |
| ALDX | ALDEYRA THERAPEUTICS INC | 1,155,300 | $4,621 | 2.8% | $7.86 | -2.9% | COM | 01438T106 |
| — | ARENA PHARMACEUTICALS INC | 45,000 | $4,182 | 2.5% | $50.17 | — | COM NEW | 040047607 |
| AGL | AGILON HEALTH INC | 150,000 | $4,050 | 2.4% | $31.52 | -22.8% | COM | 00857U107 |
| — | MORPHIC HLDG INC | 72,898 | $3,454 | 2.1% | $57.35 | — | COM | 61775R105 |
| PRQR | PROQR THRAPEUTICS N V | 356,617 | $2,857 | 1.7% | $5.23 | +45.5% | SHS EURO | N71542109 |
| RCKT | ROCKET PHARMACEUTICALS INC | 128,705 | $2,810 | 1.7% | $27.28 | 0.0% | COM | 77313F106 |
| — | PROTHENA CORP PLC | 52,100 | $2,574 | 1.5% | — | — | Call | G72800908 |
| — | PROGYNY INC | 50,000 | $2,518 | 1.5% | — | — | Put | 74340E953 |
| STTK | SHATTUCK LABS INC | 260,243 | $2,215 | 1.3% | $18.73 | -26.5% | COM | 82024L103 |
| CGTX | COGNITION THERAPEUTICS INC | 301,979 | $1,909 | 1.1% | $9.75 | 0.0% | COM | 19243B102 |
| — | PANACEA ACQUISITION CORP II | 195,855 | $1,900 | 1.1% | $9.77 | — | CL A SHS | G6882C106 |
| GMED | GLOBUS MED INC | 20,188 | $1,458 | 0.9% | $72.59 | 0.0% | CL A | 379577208 |
| — | ACCOLADE INC | 50,000 | $1,318 | 0.8% | $42.17 | — | COM | 00437E102 |
| CRSP | CRISPR THERAPEUTICS AG | 17,364 | $1,316 | 0.8% | $87.36 | 0.0% | NAMEN AKT | H17182108 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 68,800 | $1,313 | 0.8% | $24.79 | -11.2% | COM | 462260100 |
| — | SIO GENE THERAPIES INC | 802,180 | $1,035 | 0.6% | $1.98 | — | COMMON | 829399104 |
| MRNA | MODERNA INC | 3,700 | $940 | 0.6% | $292.38 | 0.0% | COM | 60770K107 |
| — | WEST PHARMACEUTICAL SVSC INC | 1,500 | $704 | 0.4% | — | — | Put | 955306955 |
| — | CYMABAY THERAPEUTICS INC | 166,775 | $564 | 0.3% | $3.38 | — | COM | 23257D103 |
| PRCT | PROCEPT BIOROBOTICS CORP | 20,000 | $500 | 0.3% | $36.99 | 0.0% | COM | 74276L105 |
| — | EXICURE INC | 2,426,508 | $490 | 0.3% | $1.45 | — | COM | 30205M101 |
| — | ODONATE THERAPEUTICS INC | 298,900 | $404 | 0.2% | $1.35 | — | COM | 676079106 |
| SPRY | SILVERBACK THERAPEUTICS INC | 53,815 | $358 | 0.2% | $8.13 | 0.0% | COM | 82835W108 |